Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹53Cr
Rev Gr TTM
Revenue Growth TTM
-21.27%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

SANGINITA
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -12.7 | -29.7 | 10.8 | -13.0 | 56.8 | 58.6 | 83.6 | 111.0 | -6.0 | -19.4 | -28.1 | -29.4 |
| 33 | 35 | 32 | 28 | 53 | 56 | 60 | 60 | 49 | 45 | 44 | 45 |
Operating Profit Operating ProfitCr |
| 1.7 | 3.4 | 4.3 | 4.2 | 0.2 | 2.3 | 2.0 | 1.9 | 2.0 | 1.7 | 0.8 | -4.0 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| 0 | 0 | 1 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | -1 | -3 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 79.2 | 118.8 | 800.0 | 58.6 | -480.0 | -11.4 | -59.3 | -69.6 | 91.4 | -64.5 | -409.1 | -2,085.7 |
| -0.3 | 1.0 | 1.6 | 1.6 | -1.1 | 0.5 | 0.4 | 0.2 | -0.1 | 0.2 | -1.5 | -6.4 |
| -0.1 | 0.2 | 0.3 | 0.2 | -0.3 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | -0.3 | -1.1 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 2.2 | 32.0 | -3.6 | -14.8 | 3.0 | 20.3 | -25.0 | 2.0 | 51.6 | -20.2 |
| 140 | 142 | 187 | 178 | 151 | 161 | 195 | 146 | 148 | 225 | 183 |
Operating Profit Operating ProfitCr |
| 3.2 | 3.3 | 4.1 | 4.9 | 5.2 | 2.4 | 1.4 | 2.0 | 2.6 | 2.0 | 0.2 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 2 |
Depreciation DepreciationCr | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| 2 | 2 | 5 | 5 | 5 | 1 | 0 | 1 | 1 | 1 | -3 |
| 1 | 1 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| | 1.2 | 208.9 | 14.2 | -14.6 | -77.3 | -54.4 | 19.6 | 85.0 | -19.6 | -649.7 |
| 0.8 | 0.8 | 1.8 | 2.1 | 2.1 | 0.5 | 0.2 | 0.3 | 0.5 | 0.3 | -1.9 |
| 1.3 | 0.6 | 1.8 | 2.1 | 1.8 | 0.4 | 0.2 | 0.2 | 0.4 | 0.2 | -1.3 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 8 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 26 | 26 |
| 8 | 11 | 14 | 18 | 21 | 22 | 22 | 23 | 24 | 30 | 30 |
Current Liabilities Current LiabilitiesCr | 26 | 31 | 29 | 36 | 39 | 31 | 36 | 37 | 42 | 45 | 45 |
Non Current Liabilities Non Current LiabilitiesCr | 1 | 1 | 1 | 0 | 0 | 0 | 4 | 2 | 3 | 1 | 2 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 40 | 56 | 57 | 67 | 74 | 66 | 75 | 70 | 78 | 87 | 88 |
Non Current Assets Non Current AssetsCr | 4 | 4 | 4 | 5 | 5 | 4 | 4 | 9 | 8 | 15 | 14 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | -7 | 3 | 1 | -2 | 9 | -3 | 14 | -2 | 3 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | -1 | -1 | -1 | 0 | -1 | -1 | -4 | -10 |
Financing Cash Flow Financing Cash FlowCr | 0 | 8 | -2 | 0 | 2 | -8 | 4 | -13 | 6 | 7 |
|
Free Cash Flow Free Cash FlowCr | 0 | -8 | 2 | 0 | -2 | 8 | -4 | 13 | -6 | -6 |
| 20.1 | -663.6 | 80.9 | 15.0 | -47.8 | 1,116.1 | -862.7 | 3,292.6 | -298.3 | 529.8 |
CFO To EBITDA CFO To EBITDA% | 4.8 | -150.6 | 35.3 | 6.4 | -19.4 | 219.0 | -109.6 | 450.9 | -58.0 | 70.0 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 41 | 90 | 111 | 127 | 33 | 36 | 33 | 34 | 23 |
Price To Earnings Price To Earnings | 0.0 | 36.7 | 26.0 | 28.1 | 37.8 | 43.8 | 104.5 | 79.0 | 43.3 | 37.5 |
Price To Sales Price To Sales | 0.0 | 0.3 | 0.5 | 0.6 | 0.8 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
Price To Book Price To Book | 0.0 | 1.5 | 2.9 | 3.1 | 3.3 | 0.8 | 0.9 | 0.8 | 0.8 | 0.4 |
| 5.5 | 13.4 | 14.6 | 15.2 | 19.5 | 16.0 | 25.8 | 20.2 | 16.8 | 10.6 |
Profitability Ratios Profitability Ratios |
| 4.6 | 6.6 | 6.2 | 6.6 | 7.2 | 4.5 | 3.4 | 4.9 | 5.0 | 3.6 |
| 3.2 | 3.3 | 4.1 | 4.9 | 5.2 | 2.4 | 1.4 | 2.0 | 2.6 | 2.0 |
| 0.8 | 0.8 | 1.8 | 2.1 | 2.1 | 0.5 | 0.2 | 0.3 | 0.5 | 0.3 |
| 10.3 | 8.7 | 13.3 | 13.4 | 10.6 | 5.3 | 3.4 | 4.4 | 5.0 | 4.0 |
| 6.6 | 4.0 | 11.0 | 11.2 | 8.7 | 1.9 | 0.9 | 1.0 | 1.9 | 1.1 |
| 2.5 | 1.9 | 5.7 | 5.5 | 4.3 | 1.1 | 0.4 | 0.5 | 0.9 | 0.6 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Sanginita Chemicals Limited is a Gujarat-based manufacturer of inorganic metal-based chemicals, currently undergoing a transformative pivot. Historically focused on copper derivatives, the company is transitioning into a diversified conglomerate with significant interests in renewable energy following a major change in corporate control and management.
---
### **Strategic Pivot: The Agastya Green Energy Integration**
As of **March 2026**, Sanginita Chemicals is executing a fundamental shift in its business model, moving from a pure-play chemical manufacturer to an integrated energy and chemical platform.
* **Acquisition of Agastya Green Energy Limited (AGEL):** The company is acquiring a **100% stake** in **AGEL** for **Rs. 19.95 Crore** (**95,00,000 shares at Rs. 21 per share**). This acquisition includes:
* **Agastya Energy Industries Private Limited** (Wholly-owned subsidiary).
* **BN UP Kusum Solar 1 Private Limited** and **IMC Solar BDN LLP** (Associate entities).
* **Strategic Objective:** Entry into high-growth sectors including **Solar Panel Manufacturing**, **EPC (Engineering, Procurement, and Construction)**, and **Power Generation**. This diversification is intended to mitigate the sectoral risks inherent in the volatile chemical industry.
* **Change in Control:** Following a **Share Swap and Share Purchase Agreement (SSSPA)** dated **March 20, 2026**, **B N G Investment LLC** and **Mr. Anubhav Agarwal** are set to become the new Promoters.
* **Open Offer:** An offer has been extended to public shareholders to acquire **1,56,89,957 equity shares** (**26%** of the emerging voting capital) at **Rs. 13.55 per share**. Post-transaction, **B N G Investment LLC** is projected to hold **64.66%** of the expanded capital.
---
### **Core Chemical Operations & Manufacturing Infrastructure**
Despite the diversification, the company maintains a robust manufacturing base for inorganic chemicals used in dyes, pigments, pharmaceuticals, and electroplating.
* **Centralized Facility:** Operations are consolidated at **Unit II** in Chhatral, Gujarat, spanning **11,028 sq. meters**.
* **Production Capacity:**
| Product | Capacity (MT / P.A.) |
| :--- | :--- |
| **Copper Sulphate** | **8,400** (Expanded from 5,400 in June 2024) |
| **Cuprous Chloride** | **6,000** |
| **Cupric Chloride & Others** | **800** |
* **Regulatory Standing:** Holds **GPCB** (Gujarat Pollution Control Board) consent for **45** chemical products, valid until **February 25, 2028**, with an authorized manufacturing limit of **8,700 MT per month**.
* **Quality Standards:** **ISO 9001:2015** certified. The company operates an **in-house laboratory** for quality testing and process optimization, which is critical for maintaining industrial specifications and developing new product lines.
---
### **Financial Restructuring & Capital Allocation**
The company has aggressively restructured its balance sheet to fund expansion and improve solvency.
* **Capital Raising (2024-2026):**
* **Rights Issue (June 2024):** Raised **Rs. 15.54 Crore** at **Rs. 18 per share**. Funds were deployed for working capital (**Rs. 6.59 Cr**), CAPEX (**Rs. 5.00 Cr**), and debt repayment.
* **Preferential Issue (2026):** Issued **1,91,57,080 shares** at **Rs. 13.05** to raise **Rs. 24.99 Crore** in cash, alongside a share swap of **1,52,87,356 shares** for the AGEL acquisition.
* **Expanded Limits:** Authorized capital was increased from **Rs. 27 Crore** to **Rs. 77 Crore** in March 2026. Borrowing and investment limits (Section 180/186) have both been raised to **Rs. 100 Crore**.
* **Debt Profile:** The company utilized Rights Issue proceeds to reduce high-interest debt, significantly improving the **Debt-Equity Ratio**. However, it still carries **Rs. 305.30 Lakhs** in unsecured loans from the promoter group, repayable on demand.
---
### **Operational Efficiency & Financial Performance**
While turnover has grown due to higher volumes and realization values, profitability remains sensitive to external cost pressures.
**Comparative Financial Metrics:**
| Metric | FY 2023-24 | FY 2022-23 | Variance Analysis |
| :--- | :--- | :--- | :--- |
| **Fixed Assets Turnover** | **27.01 Times** | **20.94 Times** | Improved asset utilization |
| **Inventory Turnover** | **5.89 Times** | **7.77 Times** | Slower inventory cycle |
| **Debtors Turnover** | **7.16 Times** | **9.12 Times** | Lengthening collection period |
| **Interest Coverage** | **1.68 Times** | **2.03 Times** | Margin pressure vs. debt cost |
* **Profitability Trends:** EBITDA and PAT have faced headwinds from **inflationary input costs** and increased **depreciation**. The company operates on a formula-based pricing model but often struggles to pass on 100% of raw material spikes (Copper, Nickel, Sulphuric Acid) to customers immediately.
* **Asset Management:** The company follows a strict **no-capitalization-of-interest** policy for fixed assets and maintains a direct-to-customer model to eliminate intermediary costs.
---
### **Risk Matrix & Mitigation**
Investors should note the following concentration and regulatory risks:
* **Concentration Risks:**
* **Revenue:** The **Top 10 customers** accounted for over **68%** of revenue in FY23.
* **Supply:** The **Top 10 suppliers** account for approximately **70%** of raw material purchases.
* **Commodity & Currency Exposure:** Raw materials are linked to global LME prices and **USD exchange rates**. The lack of long-term fixed-price supply contracts exposes the company to spot market volatility.
* **Environmental & Safety Compliance:** Operations involve hazardous **Chlorine gas**. While GPCB consents are active until **2028**, any environmental non-compliance poses a threat to the "License to Operate."
* **Governance & Continuity:**
* The registered office lease expires on **December 31, 2026**.
* There is currently **no non-compete agreement** with the former corporate promoter, **Sanginita Industries LLP**, which has similar business objects.
* The company has a history of **delayed regulatory filings** regarding SEBI LODR and Takeover Regulations.
---
### **Future Outlook**
The "New Sanginita" is positioned as a dual-engine entity. While the **Chemical Segment** focuses on increasing capacity utilization (currently at **~50%**) and leveraging the expanded Copper Sulphate line, the **Renewable Energy Segment** (via AGEL) is expected to become the primary driver of long-term valuation. The success of this transition depends on the seamless integration of the new management team and the effective deployment of the **Rs. 24.99 Crore** raised in the latest preferential round.